Abstract
The expression of the invasive (I+ or I-) phenotypes determines cancer metastasis (M+ or M- phenotype). The invasive (I+ or I-) phenotypes can be divided according to time and site of expression into subphenotypes, which can be assessed separately. At various sites along the metastatic pathway the expression of the I phenotypes can be accompanined by the presence of uncontrolled growth (G+ phenotype) or its absence (G- phenotype). Various combinations of the I and G phenotypes determine the behaviour of metazoan or parasitic cells under normal, pathological non-neoplastic and neoplastic conditions. Although the G+I+M+ combination correlates with full malignancy, the sequence of events leading to the acquisition of these phenotypes during tumor development is not clear. Conditional invasion in experimental systems indicates that a tumor may be invasive and metastatic when part of its population temporarily expresses the I+ phenotype. These experiments further stress the importance of the tumor-host ecosystem for the regulation of the I phenotypes. As distinct from some parasites, the invasive morphotype of vertebrate cells cannot be simply identified. Nevertheless, within the tumor-host ecosystem morphological correlates of the activities of invasive cells may be recognized. They reflect one or more of the I+ functions, namely: motility; loss of homotypic cell-cell adhesion; establishment of alternative cell-substrate and heterotypic cell-cell adhesion; breakdown of extracellular matrices. These functions are not exclusive for I+ tumor cells, and neither are the molecular markers investigated so far. Oncogene activation leads mainly to G+ expression, and in this way serves as a signal amplifier for the I and M phenotypes. Attractive candidate molecular markers of I phenotypes are: regulators of hydrolase activities; cell-cell adhesion molecules; cell surface receptors. From data presently available, we hypothesize that invasion depends upon the balance between an I+ and an I- pathway, with both pathways being sensitive to stimulation and inhibition.
Similar content being viewed by others
References
Fidler, IJ: Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38: 2651–2660, 1978
Billington, WD: Biology of the trophoblast. In: Bishop, MWH (ed) Advances in Reproductive Physiology, Vol. 5. Logos Press Ltd, U.K., 1971, pp 27–66
Duijvestijn, A, Hamann, A: Mechanisms and regulation of lymphocyte migration. Immunology Today 10: 23–28, 1989
DeBaetselier, P, Roos, E, Brys, L, Remels, L, Gobert, M, Dekegel, D, Segal, S, Feldman, M: Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells. Cancer Metast Rev 3: 5–24, 1984
Mareel MM, De Baetselier P, Van Roy FM: Mechanisms of invasion and metastasis. CRC Press Inc. Time Mirror Books, 1991, in press
Isberg, RR, Falkow, S: A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 317: 262–264, 1985
Katz, M, Despommier, DD, Gwadz, R: Parasitic Diseases. Springer-Verlag, New York, 1989
Costa J, Rabson AS: Generalised Kaposi's sarcoma is not a neoplasm. Lancet i: 58, 19839
Nakamura, S, Salahuddin, SZ, Biberfeld, P, Ensoli, B, Markham, PD, Wong-Staal, F, Gallo, RC: Kaposi's sarcoma cells: long-term culture with growth factor from retro-virus-infected CD4+ T cells. Science 242: 426–430, 1988
Salahuddin, CZ, Nakamura, S, Biberfeld, P, Kaplan, MH, Markham, PD, Larsson, L, Gallo, RC: Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 242: 430–433, 1988
Krementz, ET, Cerise, EJ, Foster, DS, Morgan, LRJr: Metastases of undetermined source. Curr Problems in Cancer 4: 1–37, 1979
Zajicek, G: Long survival with micrometastasis. At least 9% of breast cancer patients carry metastases for more than 10 years. The Cancer J 1: 414–415, 1987
VanRoy, FM, Messiaen, L, Liebaut, G, Gao, J, Dragonetti, CH, Fiers, WC, Mareel, MM: Invasiveness and metastatic capability of rat fibroblast-like cells before and after transfection with immortalizing and transforming genes. Cancer Res 46: 4787–4795, 1986
Coopman, P, VanRoy, F, Dragonetti, C, Gao, J, Fiers, W, Meneguzzi, G, Mareel, M: Tumorigenicity, invasiveness and metastatic capability of FR3T3 rat cells before and after transfection with bovine papilloma virus type 1 DNA. Clin Expl Metastasis 7: 69–84, 1989
Van Roy FM, Coopman P, Suffys P, Liebaut G, Vleminckx K, Gao J, Dragonetti CH, Fiers W, Mareel MM: Effect of oncogene transfection or passage in vivo on malignant phenotypes of Rat2 cells. Anticancer Res (in press)
Khokha, R, Waterhouse, P, Yagel, S, Lala, P, Overall, C, Norton, G, Denhardt, J: Oncogenicity conferred on Swiss 3T3 cells by reducing TIMP. Science 243: 947–950, 1989
Meyvisch, C, Storme, GA, Bruyneel, E, Mareel, MM: Invasiveness and tumorigenicity of MO4 mouse fibrosarcoma cells pretreated with microtubule inhibitors. Clin Expl Metastasis 1: 17–28, 1983
Owens, RB, Smith, HS, Hackett, AJ: Epithelial cell cultures from normal glandular tissue of mice. J Natl Cancer Inst 53: 261–269, 1974
Mareel M, Coopman P, Dragonetti C, Fiers W, Gao J, Messiaen L, Van Roy F: Spontaneous and oncogene-mediated acquisition of the invasive phenotype by cells in culture. Tumor progression and Metastasis 179–188, 1988
Krief, P, Saint-Ruf, C, Bracke, M, Boucheix, C, Billard, C, Billard, M, Cassingena, R, Jasmin, C, Mareel, M, Azzarone, B: Acquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of HLA class I, class II and integrin β3 and increased expression of c-myc. Int J Cancer 43: 658–664, 1989
Carloni, G, Paterson, H, Mareel, M, Augery-Bourget, Y, Sahraoui, J, Rubinstein, E, Suarez, H, Azzarone, B: N-ras dependent revertant phenotype in human HT1080 fibrosarcoma cells is associated with loss of proliferation within normal tissues and expression of an adult membrane antigenic phenotype. Oncogene 4: 873–880, 1989
Liotta, LA: Tumor invasion and metastases — Role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 46: 112–113, 1986
Waghorne, C, Thomas, M, Lagarde, A, Kerbel, RS, Breitman, ME: Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. Cancer Res 48: 6109–6114, 1988
DeBaetselier, P, Roos, E, VanHecke, D, Verschaeve, L, Brys, L, Verschueren, H: Syngeneic in vivo passage of the murine BW 5147 lymphoma results in the expression of a stable metastatic phenotype. Int J Cancer 41: 720–726, 1988
Van Hecke D, Verschueren H, De Baetselier P: Identification of T-cell antigens, expressed by metastatic T-cell hybridomas and lymphomas. Int J Cancer (in press)
Cuzin, F, Meneguzzi, G, Binétruy, B, Cerni, C, Connan, G, Grisoni, M, DeLapeyrière, O: Stepwise tumoral progression in rodent fibroblasts transformed with bovine papilloma virus type 1 (BPV1) DNA. In: Howley, PM, Broker, TR (eds) Papillomaviruses: Molecular and Clinical Aspects. Alan R. Liss Inc., New York, 1985, pp 473–486
Cajot, J-F, Sordat, B, Bachmann, F: Human primary colon carcinomas xenografted into nude mice. II. Modulation of tumor plasminogen activator activity by the host tissue environment. J Natl Cancer Inst 77: 1099–1107, 1986
Gabbert, H: Mechanism of tumor invasion: evidence from in vivo observations. Cancer Metastasis Rev 4: 293–309, 1985
Roos, E, Van dePavert, IV: Inhibition of lymphoma invasion and liver metastasis formation by pertussis toxin. Cancer Res 47: 5439–5444, 1987
Verschueren, H, Dekegel, D, DeBaetselier, P: Development of a monolayer invasion assay for the discrimination and isolation of metastatic lymphoma cells. Invasion Metastasis 7: 1–15, 1987
Bauer, EA, Gordon, JM, Reddick, ME, Eisen, AZ: Quantitation and immunocytochemical localization of human skin collagenase in basal cell carcinoma. J Invest Dermatol 89: 363–367, 1977
Welch, DR, Schissel, DJ, Howrey, RP, Aeed, PA: Tumorelicited polymorphonuclear cells, in contrast to ‘normal’ circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci USA 86: 5859–5863, 1989
Lee, AK: Basement membrane and endothelial antigens: their role in evaluation of tumor invasion and metastasis. In: DeLellis, RA (ed) Advances in Immunohistochemistry. Raven Press, New York, 1988, pp 363–393
Willis, RA: Pathology of Tumors. 3rd Edition. Butterworths, London, 1960
Barr, LC, Carter, RL, Davies, AJS: Encapsulation of tumours as a modified wound healing response. Lancet ii: 135–137, 1988
Mareel, MM, VanRoy, FM, Messiaen, LM, Boghaert, ER, Bruyneel, EA: Qualitative and quantitative analysis of tumour invasion in vivo and in vitro. J Cell Sci Suppl 8: 141–163, 1987
McKerrow, JH, Jones, P, Sage, H, Pino-Heiss, S: Proteinases from invasive larvae of the trematode parasite Schistosoma mansoni degrade connective-tissue and basement-membrane macromolecules. Biochem J 231: 47–51, 1985
Bloom, HJG, Richardson, WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359–377, 1957
Mareel, MM: Recent aspects of tumor invasiveness. Int Rev Exp Path 22: 65–129, 1980
Albrechtsen, R, Nielsen, M, Wewer, U, Engvall, E, Ruoslahti, E: Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res 41: 5076, 1981
Ehrmann, RL, Dwyer, IM, Yavner, D, Hancock, WW: An immunoperoxidase study of laminin and type IV collagen distribution in carcinoma of the cervix and vulva. Obstet Gynecol 72: 257, 1988
Sträuli, P, In-Albon, A, Haemmerli, G: Morphological studies on V2 carcinoma invasion and tumor-associated connective tissue changes in the rabbit mesentery. Cancer Res 43: 5403–6410, 1983
Wood, SJr: Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. A M A Arch Pathol 66: 550–568, 1958
Mareel, MM, DeMets, M: Anti-invasive activities of experimental chemotherapeutic agents. Critical Rev Oncol/Hematol 9: 263–303, 1989
Maslow, DE, Goldrosen, MH: Relationship of in vitro cell motility and colonization potential in a mouse colon adenocarcinoma (MCA-38) cell line. Invasion Metastasis 8: 133–142, 1988
Verschueren, H, Dekegel, D, DeBaetselier, P: Difference in motile behavior between lymphoma variants with different invasive and metastatic capabilities. Invasion Metastasis 8: 31–44, 1988
Partin, AW, Schoeniger, JS, Mohler, JL, Coffey, DS: Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci USA 86: 1254–1258, 1989
Taniguchi, S, Tatsuka, M, Nakamatsu, K, Inoue, M, Sadano, H, Okazaki, H, Iwamoto, H, Baba, T: High invasiveness associated with augmentation of motility in a fos-transferred highly metastatic rat 3Y1 cell line. Cancer Res 49: 6738–6744, 1989
Liotta, LA, Mandler, R, Murano, G, Katz, DA, Gordon, RK, Ching, PK, Schiffmann, E: Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83: 3302–3306, 1986
Goodman, SL, Vollmers, HP, Birchmeier, W: Control of cell locomotion: Perturbation with an antibody directed against specific glycoproteins. Cell 41: 1029–1038, 1985
Stoker, M, Gherardi, E, Perryman, M, Gray, J: Scatter factor is a fibroblast-derived modulator of epithelial cell motility. Nature 327: 239–242, 1987
Grey, A-M, Schor, AM, Rushton, G, Ellis, I, Schor, SL: Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci USA 86: 2438–2442, 1989
Bracke, ME, VanCauwenberge, RM-L, Storme, GA, Coopman, P, VanLarebeke, N, Mareel, MM: Action mechanisms of anti-invasive agents. Anticancer Res 6: 1273–1278, 1986
Zimmerman, A, Keller, HU: Locomotion of tumor cells as an element of invasion and metastasis. Biomed Pharmacother 41: 337–344, 1987
Coman, DR: Decreased mutual adhesiveness, a property of cells from squamous cell carcinomas. Cancer Res 4: 625–629, 1944
Auerbach, R, Lu, WC, Pardon, E, Gumkowski, F, Kaminska, G, Kaminski, M: Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Res 47: 1492–1496, 1987
Behrens, J, Mareel, MM, VanRoy, FM, Birchmeier, W: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomurulin-mediated cell-cell adhesion. J Cell Biol 108: 2435–2447, 1989
Raz, A, Ben-Ze'ev, A: Cell-contact and-architecture of malignant cells and their relationship to metastasis. Cancer Metastasis Rev 6: 3–21, 1987
Nicolson, GL: Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayers. J Histochem Cytochem 30: 214–220, 1982
Iwamoto, Y, Robey, FA, Graf, J, Sasaki, M, Kleinman, HK, Yamada, Y, Martin, GR: YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 238: 1132–1134, 1987
Humphries, MJ, Olden, K, Yamada, KM: A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 233: 467, 1986
Chung, DC, Zetter, BR, Brodt, P: Lewis lung carcinoma variants with differing metastatic specificities adhere preferentially to different defined extracellular matrix molecules. Invasion Metastasis 8: 103–117, 1988
Albini, AA, Graf, J, Kitten, GT, Kleinman, HK, Martin, GR, Veillette, A, Lippman, ME: 17β-estradiol regulates and v-Ha-ras transfection constitutively enhances MCF-7 breast cancer cell interactions with basement membrane. Proc Natl Acad Sci USA 83: 8182–8186, 1986
Bracke, ME, Castronovo, V, VanCauwenberge, RML, Coopman, P, Vakaet, LJr, Strojny, P, Foidart, J-M, Mareel, MM: The anti-invasive flavonoid (+)-catechin binds to laminin and abrogates the effect of laminin on cell morphology and adhesion. Exp Cell Res 173: 193–205, 1987
Jones, PA, DeClerck, YA: Extracellular matrix destruction by invasive tumor cells. Cancer Metastasis Rev 1: 289–317, 1982
Zucker, S: A critical appraisal of the role of proteolytic enzymes in cancer invasion: emphasis on tumor surface proteinases. Cancer Invest 6: 219–231, 1988
Tryggvason, K, Höyhtyä, M, Salo, T: Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907: 191–217, 1987
Mareel, MM, VanRoy, FM: Are oncogenes involved in invasion and metastasis? Anticancer Res 6: 419–436, 1986
Nicolson, GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res 47: 1473–1487, 1987
Muschel, RJ, McKenna, WG: Oncogenes and tumor progression. Anticancer Res 9: 1395–1406, 1989
Eccles, S: The role of oncogenes in metastasis. Cancer Topics 7: 42–46, 1989
VanRoy, FM, Mareel, MM: Oncogenes and tumor progression: state of the art. In: Schirrmacher, V, Schwartz-Albiez, R (eds) Cancer Metastasis, Springer-Verlag, Berlin, 1990, pp 27–35
Yoshida, K, Hamatani, K, Koide, H, Ikeda, H, Nakamura, N, Akiyama, M, Tsuchiyama, H, Nakayama, E, Shiku, H: Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers. Cancer Res 48: 5503–5509, 1988
Vogelstein, B, Fearon, ER, Hamilton, ST et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525–532, 1988
Bos, JL: Ras oncogenes in human cancer: a review. Cancer Res 49: 4682–4689, 1989
Balmain, A, Ramsden, M, Bowden, GT, Smith, J: Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307: 658–660, 1984
Brown, K, Quintanilla, M, Ramsden, M, Kerr, IB, Young, S, Balmain, A: v-ras genes from Harvey and BALB murine sacroma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell 46: 447–456, 1986
Egan, SE, Wright, JA, Jarolim, L, Yanagihara, K, Bassin, RH, Greenberg, AH: Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238: 202–205, 1987
Collard, JG, Roos, E, LaRivière, G, Habets, GGM: Genetic analysis of invasion and metastasis. Cancer Surveys 7: 691–710, 1988
Pohl, J, Radler-Pohl, A, Schirrmacher, V: A model to account for the effects of oncogenes, TPA, and retinoic acid on the regulation of genes involved in metastases. Cancer Metastasis Rev 7: 347–356, 1988
Kerbel, RS, Waghorne, C, Man, MS, Elliott, B, Breitman, ML: Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection. Proc Natl Acad Sci USA 84: 1263–1267, 1987
Dano, K, Andreasen, PA, Grondahl-Hansen, J, Kristensen, P, Nielsen, LS, Skriver, L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44: 139–266, 1985
Murphy, G, Reynolds, JJ, Hembry, FM: Metalloproteinases and cancer invasion and metastasis. Int J Cancer 44: 757–760, 1989
Baici, A, Knöpfel, M, Keist, R: Tumor-host interactions in the rabbit V2 carcinoma: stimulation of cathepsin B in host fibroblasts by a tumor-derived cytokine. Invasion Metastasis 8: 143–158, 1988
Nakijama, M, Irimura, T, Nicolson, GL: Heparanases and tumor metastasis. J Cell Biochem 36: 157–167, 1988
Mignatti, P, Robbins, E, Rifkin, DB: Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487–489, 1986
Ossowski, L: In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase. J Cell Biol 107: 2437–2445, 1988
Burtin, P, Fondaneche, M-C: Receptor for plasmin on human carcinoma cells. J Natl Cancer Inst 80: 762–765, 1988
Stephens, RW, Pöllänen, J, Tapiovaara, H, Leung, K-C, Sim, P-S, Salonen, E-M, Ronne, E, Behrendt, N, Dano, K, Vaheri, A: Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol 108: 1987–1995, 1989
Blasi, F, Vassalli, J-D, Dano, K: Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol 104: 801–804, 1987
Schultz, RM, Silberman, S, Persky, B, Bajkowski, AS, Carmichael, DF: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48: 5539–5545, 1988
Takeichi, M, Yoshida-Noro, C, Shirayoshi, Y, Hatta, K: Calcium-dependent cell-cell adhesion system: its molecular nature, cell type specificity, and morphogenetic role. In: Edelman, GM, Thiery, J-P (eds) The Cell in Contact. John Wiley & Sons Inc. New York, 1985, pp 219–232
Gumbiner, B, Stevenson, B, Grimaldi, A: The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 107: 1575–1587, 1988
Nagafuchi, A, Shirayoshi, Y, Okazaki, K, Yasuda, K, Takeichi, M: Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature 329: 341–343, 1987
Ekblom, P: Determination and differentiation of the nephron. Med Biol (Helsinki) 50: 139–160, 1981
Vestweber, D, Kemler, R: Identification of putative cell adhesion domain of uvomorulin. EMBO J 4: 3393–3398, 1985
Sher, BT, Bargatze, R, Holzmann, B, Gallatin, WM, Matthews, D, Wu, N, Picker, L, Butcher, EC, Weissman, IL: Homing receptors and metastasis. Adv Cancer Res 51: 361–390, 1988
Roossien, FF, deRijk, D, Bikker, A, Roos, E: Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1-deficient mutants. J Cell Biol 108: 1979–1985, 1989
Rice, GE, Bevilacqua, MP: An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246: 1303–1306, 1989
Nickoloff, BJ, Griffiths, CEM, Baadsgaard, O, Voorhees, JJ, Hanson, CA, Cooper, KD: Markedly diminished epidermal keratinocyte expression of intercellular adhesion molecule-1 (ICAM-1) in Sézary syndrome. JAMA 261: 2217–2221, 1989
Johnson, JP, Stade, BG, Holzmann, B, Schwäble, W, Riethmüller, G: De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 86: 641–644, 1989
Terranova, VP, Rao, CN, Kalebic, T, Margulies, IM, Liotta, LA: Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci USA 80: 444–448, 1983
Lissitzky, JC, Bouzon, M, Loret, E, Poupon, MF, Martin, PM: Laminin-mediated adhesion in metastatic rat rhabdomyosarcoma cell lines involves prominent interactions with the laminin E8 fragment. Clin Exp Metastasis 7: 469–480, 1989
Sonnenberg, A, Modderman, PW, Hogervorst, F: Laminin receptor on platelets is the integrin VLA-6. Nature 336: 487–489, 1988
Kleinman, HK, Ogle, RC, Cannon, FB, Little, CD, Sweeney, TM, Luckenbill-Edds, L: Laminin receptors for neurite formation. Proc Natl Acad Sci USA 85: 1282–1286, 1988
Albini, AA, Aukerman, SL, Ogle, RC, Noonan, DM, Fridman, R, Martin, GR, Fidler, IJ: The in vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants. Clin Exp Metastasis 7: 437–451, 1989
Schirrmacher, V, Altevogt, P, Fogel, M, Dennis, J, Waller, CA, Barz, D, Schwartz, R, Cheingsong-Popov, R, Springer, G, Robinson, PG, Nebe, J, Brossmer, W, Vlodavsky, I, Paweletz, N, Zimmerman, H-P, Uhlenbruck, G: Importance of cell surface carbohydrates in cancer cell adhesion, invasion and metastasis. Does sialic acid direct metastatic behavior? Invasion Metastasis 2: 313–360, 1982
Smets, LA, VanBeek, WP: Carbohydrates of the tumor cell surface. Biochim Biophys Acta 738: 237–249, 1984
Bolscher, JGM, Schallier, DCC, Smets, LA, VanRooy, H, Collard, JG, Bruyneel, EA, Mareel, MMK: Effects of cancer-related and drug-induced alterations in surface carbohydrates on the invasive capacity of mouse and rat cells. Cancer Res 46: 4080–4086, 1986
Bolscher, JGM, Schallier, DCC, VanRooy, H, Storme, GA, Smets, LA: Modification of cell surface carbohydrates and invasive behavior by an alkyllysophospholipid. Cancer Res 48: 977–982, 1988
Bruyneel, EA, Debray, H, DeMets, M, Mareel, MM, Montreuil, J: Altered glycosylation in Madin-Darby canine kidney (MDCK) cells after transformation by murine sarcoma virus. Clin Expl Metastasis 8: 241–253, 1990
Bruyneel, EA, DeMets, M, Dragonetti, CH, Hooghe, RJ, DiVirgilio, S, Mareel, MM: Effect of glycosylation inhibitors on N-glycosylpeptides and on invasion of malignant mouse MO4 cells in vitro. J Cell Sci 95: 279–286, 1990
Vakaet, L: The initiation of gastrular ingression in the chick blastoderm. Amer Zool 24: 555–562, 1984
Bellairs, R, VanPeteghem, MC: Gastrulation: is it analogous to malignant invasion? Amer Zool 24: 563–570, 1984
Armstrong, PB: Invasiveness of non-malignant cells. In: Mareel, MM, Calman, KC (eds) Invasion. Experimental and Clinical Implications. Oxford University Press, Oxford, 1984, pp 126–167
Arkin, CF, Millard, M, Medeiros, J: Giant invasive cholesteatoma. Arch Pathol Lab Med 109: 960, 1985
Taylor, HB, Norris, HJ: Epithelial invasion of nerves in benign diseases of the breast. Cancer 20: 2245, 1967
Gabbiani, G: The myofibroblast: a key cell for wound healing and fibrocontractive diseases. In: Deyl, Z, Adam, M (eds) Connective Tissue Research: Chemistry, Biology and Physiology. Alan R. Liss, New York, 1981, pp 183–194
Cairns, J: Cancer. Science and Society. W.H. Freeman and Company, San Francisco, 1978
Sherbet GV: The Metastatic Spread of Cancer. Macmillan Press Ltd., 1987
Dvoretzky, I, Fisher, BK, Haker, O: Mutilating basal cell epithelioma. Arch Dermat 114: 2496250, 1978
Mareel, MM, DeMets, M: Effect of microtubule inhibitors on invasion and on related activities of tumor cells. Int Rev Cytol 90: 125–167, 1984
Bracke, ME, VanCauwenberge, RM-L, Mareel, MM: (+)-Catechin inhibits the invasion of malignant fibrosarcoma cells into chick heart in vitro. Clin Expl Metastasis 2: 161–170, 1984
Storme, GA, Bruyneel, EA, Schallier, DC, Bolscher, JG, Berdel, BE, Mareel, MM: Effect of lipid derivatives on invasion in vitro and on surface glycoproteins of three rodent cell types. Lipids 22: 847–850, 1987
Storme, G, Mareel, MM: Effect of anticancer agents on invasion of mouse fibrosarcoma cells in vitro. Oncology 38: 182–186, 1981
Scher, HI, Yagoda, A: Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors. Am J Med 82: 6–28, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mareel, M.M., Van Roy, F.M. & De Baetselier, P. The invasive phenotypes. Cancer Metast Rev 9, 45–62 (1990). https://doi.org/10.1007/BF00047588
Issue Date:
DOI: https://doi.org/10.1007/BF00047588